Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma

被引:24
作者
Kosmalski, Marcin [1 ]
Sliwinska, Agnieszka [2 ]
Drzewoski, Jozef [3 ]
机构
[1] Med Univ Lodz, Dept Clin Pharmacol, PL-90153 Lodz, Poland
[2] Med Univ Lodz, Dept Nucl Acids Biochem, PL-92213 Lodz, Poland
[3] Med Univ Lodz, Cent Teaching Hosp, PL-92213 Lodz, Poland
关键词
non-alcoholic fatty liver disease; type 2 diabetes mellitus; coexistence; epidemiology; diagnosis; pathogenesis; INSULIN-RESISTANCE; GUT MICROBIOTA; HEPATIC STEATOSIS; FETUIN-A; RISK; ACID; PREVALENCE; OBESITY; BIOPSY; NAFLD;
D O I
10.3390/biomedicines11041097
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In clinical practice, we often deal with patients who suffer from non-alcoholic fatty liver disease (NAFLD) concurrent with type 2 diabetes mellitus (T2DM). The etiopathogenesis of NAFLD is mainly connected with insulin resistance (IR) and obesity. Similarly, the latter patients are in the process of developing T2DM. However, the mechanisms of NAFLD and T2DM coexistence have not been fully elucidated. Considering that both diseases and their complications are of epidemic proportions and significantly affect the length and quality of life, we aimed to answer which of these diseases appears first and thereby highlight the need for their diagnosis and treatment. To address this question, we present and discuss the epidemiological data, diagnoses, complications and pathomechanisms of these two coexisting metabolic diseases. This question is difficult to answer due to the lack of a uniform procedure for NAFLD diagnosis and the asymptomatic nature of both diseases, especially at their beginning stages. To conclude, most researchers suggest that NAFLD appears as the first disease and starts the sequence of circumstances leading ultimately to the development of T2DM. However, there are also data suggesting that T2DM develops before NAFLD. Despite the fact that we cannot definitively answer this question, it is very important to bring the attention of clinicians and researchers to the coexistence of NAFLD and T2DM in order to prevent their consequences.
引用
收藏
页数:23
相关论文
共 155 条
[1]   Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes [J].
Abderrahmani, Amar ;
Yengo, Loic ;
Caiazzo, Robert ;
Canouil, Mickael ;
Cauchi, Stephane ;
Raverdy, Violeta ;
Plaisance, Valerie ;
Pawlowski, Valerie ;
Lobbens, Stephane ;
Maillet, Julie ;
Rolland, Laure ;
Boutry, Raphael ;
Queniat, Gurvan ;
Kwapich, Maxime ;
Tenenbaum, Mathie ;
Bricambert, Julien ;
Saussenthaler, Sophie ;
Anthony, Elodie ;
Jha, Pooja ;
Derop, Julien ;
Sand, Olivier ;
Rabearivelo, Iandry ;
Leloire, Audrey ;
Pigeyre, Marie ;
Daujat-Chavanieu, Martine ;
Gerbal-Chaloin, Sabine ;
Dayeh, Tasnim ;
Lassailly, Guillaume ;
Mathurin, Philippe ;
Staels, Bart ;
Auwerx, Johan ;
Schuermann, Annette ;
Postic, Catherine ;
Schafmayer, Clemens ;
Hampe, Jochen ;
Bonnefond, Amelie ;
Pattou, Francois ;
Froguel, Philippe .
DIABETES, 2018, 67 (07) :1310-1321
[2]   Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken Comment [J].
Abdul-Ghani, Muhammad ;
DeFronzo, Ralph A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (04) :E1897-E1899
[3]   Type 2 diabetes [J].
Ahmad, Ehtasham ;
Lim, Soo ;
Lamptey, Roberta ;
Webb, David R. ;
Davies, Melanie J. .
LANCET, 2022, 400 (10365) :1803-1820
[4]   A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes [J].
Ajmera, Veeral ;
Cepin, Sandra ;
Tesfai, Kaleb ;
Hofflich, Heather ;
Cadman, Karen ;
Lopez, Scarlett ;
Madamba, Egbert ;
Bettencourt, Ricki ;
Richards, Lisa ;
Behling, Cynthia ;
Sirlin, Claude B. ;
Loomba, Rohit .
JOURNAL OF HEPATOLOGY, 2023, 78 (03) :471-478
[5]   Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study [J].
Almahmoud, Malik H. ;
Al Khawaja, Nahla M. ;
Alkinani, Arwa ;
Khader, Yousef ;
Ajlouni, Kamel M. .
ANNALS OF MEDICINE AND SURGERY, 2021, 68
[6]  
Amiri Dash Atan Nasrin, 2017, Gastroenterol Hepatol Bed Bench, V10, pS1
[7]   Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].
Ballestri, Stefano ;
Zona, Stefano ;
Targher, Giovanni ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Nascimbeni, Fabio ;
Roverato, Alberto ;
Guaraldi, Giovanni ;
Lonardo, Amedeo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944
[8]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[9]   Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes [J].
Biondi, Giuseppina ;
Marrano, Nicola ;
Borrelli, Anna ;
Rella, Martina ;
Palma, Giuseppe ;
Calderoni, Isabella ;
Siciliano, Edoardo ;
Lops, Pasquale ;
Giorgino, Francesco ;
Natalicchio, Annalisa .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
[10]   Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk [J].
Bozzetto, L. ;
Annuzzi, G. ;
Ragucci, M. ;
Di Donato, O. ;
Della Pepa, G. ;
Della Corte, G. ;
Griffo, E. ;
Anniballi, G. ;
Giacco, A. ;
Mancini, M. ;
Rivellese, A. A. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (07) :623-629